Here is a list of my biotechs, the ones I'm holding for a December-January "pop" due to tax loss selling and/or bullish seasonality and/or insider buying:
Bought some prcs, and, of those you listed, I'm still holding arna, exas, gern (a little, from yesterday) and supg (from long ago). Still trying to find more time for researching.
5 comments:
Bought some prcs, and, of those you listed, I'm still holding arna, exas, gern (a little, from yesterday) and supg (from long ago). Still trying to find more time for researching.
See dsco? - doesn't look like the market agreed with my assessment of the data -- should I sell some??
Based on today's action and reaction to the Phase II trail data, I'd hold-on tight to every precious share.
Thanks, A, next, take a look at prcs. (Bet you're not busy making tofu dip.) http://www.praecis.com/rd/pipeline.html
Quickie on PRCS: looks cheap vis a vis pipeline and balance sheet, but I'm full up on biotechs after doubling up on AGEN today, good luck.
Post a Comment